Yang Botong, Wu Mengzhu, Zhang Xinxia, Xia Jia, Wang Lizhen, Chen Q I, Zhong Min, Tang Xiaoming
Hospital of Chengdu University of Traditional Chinese Medicine.
Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Medicine (Baltimore). 2020 Oct 2;99(40):e22266. doi: 10.1097/MD.0000000000022266.
Gestational hyperinsulinism is a metabolic disease which is widely concerned at home and abroad. It is a clinical consensus that the embryo implantation ability of patients with hyperinsulinemia is decreased and the abortion rate after implantation is high. The treatment of gestational hyperinsulinism with Multiple dietary fiber diets has been proven. However, due to the lack of evidence, there is no specific method or recommendation, it is necessary to carry out a systematic evaluation of Multiple dietary fiber diet, to provide effective evidence for further research.
The following databases will be searched from their inception to August 2020: Electronic database includes PubMed, Embase, Cochrane Library, Web of Science, Nature, Science online, Chinese Biomedical Database WanFang, VIP medicine information, and CNKI. Primary outcomes: Fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance, glycosylated hemoglobin. Additional outcomes: Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), triglycerides (TG), total serum cholesterol (TC). Data will be extracted by 2 researchers independently, risk of bias of the meta-analysis will be evaluated based on the Cochrane Handbook for Systematic Reviews (SR) of Interventions. All data analysis will be conducted by data statistics software Review Manager V.5.3. and Stata V.12.0.
The results of this study will systematically evaluate the effectiveness and safety of Multiple dietary fiber diet interventions in the treatment of gestational hyperinsulinism.
The SR of this study will summarize the current published evidence of Multiple dietary fiber for the treatment of gestational hyperinsulinism, which can further guide the promotion and application of it.
This study is a SR, the outcomes are based on the published evidence, so examination and agreement by the ethics committee are not required in this study. We intend to publish the study results in a journal or conference presentations.
OPEN SCIENCE FRA NETWORK (OSF) REGISTRATION NUMBER: August 19, 2020. osf.io/tbc7z. (https://osf.io/tbc7z).
妊娠期高胰岛素血症是一种在国内外广泛受到关注的代谢性疾病。临床共识是,高胰岛素血症患者的胚胎着床能力下降,着床后的流产率较高。已证实多种膳食纤维饮食可用于治疗妊娠期高胰岛素血症。然而,由于缺乏证据,尚无具体方法或建议,有必要对多种膳食纤维饮食进行系统评价,为进一步研究提供有效证据。
将检索以下数据库自建库至2020年8月的数据:电子数据库包括PubMed、Embase、Cochrane图书馆、Web of Science、Nature、Science online、中国生物医学数据库万方、维普医药信息和知网。主要结局:空腹血糖、空腹胰岛素、胰岛素抵抗稳态模型评估、糖化血红蛋白。附加结局:低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、甘油三酯(TG)、总血清胆固醇(TC)。数据将由2名研究人员独立提取,基于Cochrane干预系统评价手册(SR)评估荟萃分析的偏倚风险。所有数据分析将使用数据统计软件Review Manager V.5.3和Stata V.12.0进行。
本研究结果将系统评价多种膳食纤维饮食干预治疗妊娠期高胰岛素血症的有效性和安全性。
本研究的系统评价将总结目前已发表的关于多种膳食纤维治疗妊娠期高胰岛素血症的证据,可进一步指导其推广应用。
本研究为系统评价,结局基于已发表的证据,因此本研究无需伦理委员会审查和批准。我们打算在期刊上发表研究结果或在会议上进行展示。
开放科学框架(OSF)注册号:2020年8月19日。osf.io/tbc7z。(https://osf.io/tbc7z)